A carregar...

PATH-20. COMPREHENSIVE GENOMIC PROFILING COMPARING PRIMARY CNS LYMPHOMA TO SYSTEMIC DIFFUSE LARGE B CELL LYMPHOMA REVEALS BIOMARKERS INDICATING POTENTIAL BENEFIT FROM IMMUNE CHECKPOINT INHIBITORS

BACKGROUND: B-Cell Primary CNS Lymphoma (PCL) is Diffuse Large B-cell Lymphoma (DLBCL) confined to the CNS. Less than 50% of PCL patients achieve complete remission with current therapies. Comprehensive genomic profiling (CGP) may suggest novel treatment modalities including use of immune checkpoint...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Severson, Eric, Vergilio, Jo-Anne, Gay, Laurie, Daniel, Sugganth, Elvin, Julia, Suh, James, Covert, Mandy, Brown, Charlotte, Miller, Vincent, Stephens, Philip, Ross, Jeffrey, Ramkissoon, Shakti
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5693113/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.711
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!